Efficacy and safety of vemurafenib in Langerhans cell histiocytosis (LCH): A systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2022 at "Pediatric Hematology and Oncology"
DOI: 10.1080/08880018.2022.2072986
Abstract: Abstract Almost half of the patients with Langerhans cell histiocytosis (LCH) are refractory to primary induction chemotherapy or undergo reactivation. The ideal treatment modality for refractory/relapsed LCH is yet not evidenced. This review aimed to… read more here.
Keywords: vemurafenib; langerhans cell; histiocytosis lch; lch ... See more keywords
A RARE CASE REPORT ON LANGERHANS CELL HISTIOCYTOSIS(LCH) IN A 4 YR OLD CHILD.
Sign Up to like & getrecommendations! Published in 2018 at "International Journal of Approximate Reasoning"
DOI: 10.21474/ijar01/6992
Abstract: Sunil ku Agarwalla 1 , Poonam Agrawal 2 , Rina Meher 2 . 1. Associate Professor, Department of Paediatrics, MKCG Medical College and Hospital, Berhampur, Odisha 2. Senior Resident, Department of Paediatrics, MKCG Medical College… read more here.
Keywords: langerhans cell; rare case; report langerhans; histiocytosis lch ... See more keywords